Bourgeon Capital Management’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,450
| Closed | -$69.8K | – | 117 |
|
|
2024
Q1 | $69.8K | Hold |
29,450
| – | – | 0.01% | 112 |
|
|
2023
Q4 | $66.3K | Buy |
29,450
+2,500
| +9% | +$5.63K | 0.01% | 137 |
|
|
2023
Q3 | $57.1K | Buy |
26,950
+4,500
| +20% | +$9.54K | 0.01% | 137 |
|
|
2023
Q2 | $69.4K | Buy |
22,450
+4,000
| +22% | +$12.4K | 0.02% | 137 |
|
|
2023
Q1 | $99.3K | Buy |
18,450
+7,250
| +65% | +$39K | 0.02% | 117 |
|
|
2022
Q4 | $74.5K | Buy |
11,200
+500
| +5% | +$3.33K | 0.02% | 134 |
|
|
2022
Q3 | $43K | Buy |
10,700
+3,000
| +39% | +$12.1K | 0.01% | 142 |
|
|
2022
Q2 | $38K | Hold |
7,700
| – | – | 0.01% | 149 |
|
|
2022
Q1 | $47K | Sell |
7,700
-2,900
| -27% | -$17.7K | 0.01% | 148 |
|
|
2021
Q4 | $123K | Buy |
10,600
+4,547
| +75% | +$52.8K | 0.03% | 117 |
|
|
2021
Q3 | $95K | Buy |
6,053
+4,250
| +236% | +$66.7K | 0.02% | 129 |
|
|
2021
Q2 | $34K | Buy |
+1,803
| New | +$34K | 0.01% | 179 |
|